Gland atrophy following retrograde injection of methyl violet as a treatment in chronic obstructive parotitis

  • Songlin Wang
  • , Jun Li
  • , Xuanzhi Zhu
  • , Zhutao Zhao
  • , Tao Sun
  • , Hui Dong
  • , Yingguang Zhang

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Objective. The purpose of this study was to evaluate the clinical effectiveness of retrograde injection of 1% methyl violet as a treatment for chronic obstructive parotitis. Study Design. Sixteen patients with chronic obstructive parotitis were treated with retrograde injection of 1% methyl violet. Pretreatment evaluation and assessment of the treatment effect were performed by clinical and imaging methods, including sialography and sonography of the treated glands. Results. Clinical symptoms following treatment included initial acute swelling and then a decrease in parotid swellings; the final outcome was a clinical cure of the affected glands characterized by disappearance of all symptoms, absence of secretion, and complete obliteration of the main duct orifice. Posttreatment imaging showed total atrophy of the diseased glands. Conclusion. Retrograde injection of 1% methyl violet caused total atrophy of the diseased glands and brought about complete relief in all 16 patients, with no detectable side effects.

Original languageEnglish
Pages (from-to)276-281
Number of pages6
JournalOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
Volume85
Issue number3
DOIs
StatePublished - 1998

Fingerprint

Dive into the research topics of 'Gland atrophy following retrograde injection of methyl violet as a treatment in chronic obstructive parotitis'. Together they form a unique fingerprint.

Cite this